DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Gauthier S, Molinuevo JL.
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
Alzheimers Dement 2013;
9 (03) 326-331
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.